Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06992440
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:48.219371+00:00
Published At
2025-12-17T00:00:00+00:00
Record Updated At
2025-12-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pulmonary Arterial Hypertension"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-17"
protocolSection.identificationModule.nctId
"NCT06992440"
protocolSection.identificationModule.officialTitle
"Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension"
protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Pulmonary Arterial Hypertension (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.